Global Neuroprosthetics Market

Neuroprosthetics Comprehensive Study by Type (Output Neural Prosthetics, Input Neural Prosthetics), Application (Motor Neuron Disorders, Physiological Disorders, Cognitive Disorders), Technology (Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Spinal Cord Stimulation (SCS), Sacral Nerve Stimulation (SNS)) Players and Region - Global Market Outlook to 2027

Neuroprosthetics Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 11.9%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Neuroprosthetics Market Scope?
Neuroprosthetics is a device which records brains signals with an aim to find the cognitive behavior of individual. Electroencephalography (EEG) is mostly used to record in which an electrode is placed on individual scalp. Using these machines, the researchers find various kinds of signals and also identify the part of brain which is active.Growing number of hearing implant cases and rising number of neurological disorders are supplementing the growth of the very market.

Neuroprosthetics Market Dynamics:
AttributesDetails
Growth Drivers
  • Rising Number of Patients Suffering from Neurological Disorders
  • Growing Number of Hearing Loss and Cases of Diabetes
Influencing Trends
  • Rising Cases of Amputation Owing to Rising Number of Injuries
Restraints
  • Availability of Alternative Treatment Methods
  • High Cost of Neurasthenics Treatment
Road Blocks / Challenges
  • Lack of Trained Professional
Gaps & Opportunities
  • Rising Disposable Income in Emerging Countries
  • Advancement in Neurasthenics Treatment Methods


The Neuroprosthetics market study is being classified by Type (Output Neural Prosthetics and Input Neural Prosthetics), by Application and major geographies with country level break-up.

Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Neuroprosthetics market throughout the predicted period.

Medtronic (United States), Abbott (United States), Cochlear (Australia), Boston Scientific (United States), Livanova (United Kingdom), Second Sight (United States) and Med-El (Austria) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Sonova (Switzerland), Neuropace (United States), NDI Medical (United States) and Nevro (United States).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Neuroprosthetics market by Type, Application and Region.

On the basis of geography, the market of Neuroprosthetics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Asia Pacific region hold largest market share in the year 2021.

Market Influencers and their Development Strategies
In 2021, Second Sight Medical Products, a leading developer and marketer of implantable visual prostheses for creating artificial forms of useful vision for the visually impaired, have been approved by the U.S. Food and Drug Administration (FDA) for their Argus 2s retinal prosthetic system. and In 2021, Boston Scientific Corporation is FDA-cleared for its fourth-generation Vercise Genus Deep Brain Stimulation (DBS) system used to treat symptoms in patients with advanced Parkinson's disease.
In 2021, Houston Methodist School and Rice University have launched the Neuroprosthetics Collaboration - Intermediate Neuroprosthetics and Interfaces Center to focus on restoring brain function after illness or injury. Rice University and Houston Methodist have partnered to launch the Center for Translational Neural Prosthetics and Interfaces, a collaboration between scientists, clinicians, engineers, and surgeons to solve clinical problems with neural robots., In 2020, MED-El is certified by the European Medical Device Regulation (MDR). This certification makes MED-El one of the first manufacturers in the world to be certified for medical devices of the highest risk class (Class III), Class III implantable custom devices, and Class I reusable surgical instruments. and In 2020, Cochlear Limited has been approved by the US FDA to reduce the age of cochlear implantation in children with bilateral profound sensorineural hearing loss from 12 months to 9 months.


Key Target Audience
Neuroprosthetics Service Providers, End-user Industries, Potential Investors, Research Institutes, Government Agencies and Others

Neuroprosthetics Market Study: Important Years
AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Historical Period2017-2021
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Output Neural Prosthetics
  • Input Neural Prosthetics
By Application
  • Motor Neuron Disorders
  • Physiological Disorders
  • Cognitive Disorders
By Technology
  • Deep Brain Stimulation (DBS)
  • Vagus Nerve Stimulation (VNS)
  • Spinal Cord Stimulation (SCS)
  • Sacral Nerve Stimulation (SNS)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Number of Patients Suffering from Neurological Disorders
      • 3.2.2. Growing Number of Hearing Loss and Cases of Diabetes
    • 3.3. Market Challenges
      • 3.3.1. Lack of Trained Professional
    • 3.4. Market Trends
      • 3.4.1. Rising Cases of Amputation Owing to Rising Number of Injuries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Neuroprosthetics, by Type, Application, Technology and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Neuroprosthetics (Value)
      • 5.2.1. Global Neuroprosthetics by: Type (Value)
        • 5.2.1.1. Output Neural Prosthetics
        • 5.2.1.2. Input Neural Prosthetics
      • 5.2.2. Global Neuroprosthetics by: Application (Value)
        • 5.2.2.1. Motor Neuron Disorders
        • 5.2.2.2. Physiological Disorders
        • 5.2.2.3. Cognitive Disorders
      • 5.2.3. Global Neuroprosthetics by: Technology (Value)
        • 5.2.3.1. Deep Brain Stimulation (DBS)
        • 5.2.3.2. Vagus Nerve Stimulation (VNS)
        • 5.2.3.3. Spinal Cord Stimulation (SCS)
        • 5.2.3.4. Sacral Nerve Stimulation (SNS)
      • 5.2.4. Global Neuroprosthetics Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Neuroprosthetics (Price)
      • 5.3.1. Global Neuroprosthetics by: Type (Price)
  • 6. Neuroprosthetics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cochlear (Australia)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Boston Scientific (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Livanova (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Second Sight (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Med-El (Austria)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Neuroprosthetics Sale, by Type, Application, Technology and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Neuroprosthetics (Value)
      • 7.2.1. Global Neuroprosthetics by: Type (Value)
        • 7.2.1.1. Output Neural Prosthetics
        • 7.2.1.2. Input Neural Prosthetics
      • 7.2.2. Global Neuroprosthetics by: Application (Value)
        • 7.2.2.1. Motor Neuron Disorders
        • 7.2.2.2. Physiological Disorders
        • 7.2.2.3. Cognitive Disorders
      • 7.2.3. Global Neuroprosthetics by: Technology (Value)
        • 7.2.3.1. Deep Brain Stimulation (DBS)
        • 7.2.3.2. Vagus Nerve Stimulation (VNS)
        • 7.2.3.3. Spinal Cord Stimulation (SCS)
        • 7.2.3.4. Sacral Nerve Stimulation (SNS)
      • 7.2.4. Global Neuroprosthetics Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Neuroprosthetics (Price)
      • 7.3.1. Global Neuroprosthetics by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Neuroprosthetics: by Type(USD Million)
  • Table 2. Neuroprosthetics Output Neural Prosthetics , by Region USD Million (2016-2021)
  • Table 3. Neuroprosthetics Input Neural Prosthetics , by Region USD Million (2016-2021)
  • Table 4. Neuroprosthetics: by Application(USD Million)
  • Table 5. Neuroprosthetics Motor Neuron Disorders , by Region USD Million (2016-2021)
  • Table 6. Neuroprosthetics Physiological Disorders , by Region USD Million (2016-2021)
  • Table 7. Neuroprosthetics Cognitive Disorders , by Region USD Million (2016-2021)
  • Table 8. Neuroprosthetics: by Technology(USD Million)
  • Table 9. Neuroprosthetics Deep Brain Stimulation (DBS) , by Region USD Million (2016-2021)
  • Table 10. Neuroprosthetics Vagus Nerve Stimulation (VNS) , by Region USD Million (2016-2021)
  • Table 11. Neuroprosthetics Spinal Cord Stimulation (SCS) , by Region USD Million (2016-2021)
  • Table 12. Neuroprosthetics Sacral Nerve Stimulation (SNS) , by Region USD Million (2016-2021)
  • Table 13. South America Neuroprosthetics, by Country USD Million (2016-2021)
  • Table 14. South America Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 15. South America Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 16. South America Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 17. Brazil Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 18. Brazil Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 19. Brazil Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 20. Argentina Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 21. Argentina Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 22. Argentina Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 23. Rest of South America Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 24. Rest of South America Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 25. Rest of South America Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 26. Asia Pacific Neuroprosthetics, by Country USD Million (2016-2021)
  • Table 27. Asia Pacific Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 28. Asia Pacific Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 29. Asia Pacific Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 30. China Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 31. China Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 32. China Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 33. Japan Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 34. Japan Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 35. Japan Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 36. India Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 37. India Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 38. India Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 39. South Korea Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 40. South Korea Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 41. South Korea Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 42. Taiwan Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 43. Taiwan Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 44. Taiwan Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 45. Australia Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 46. Australia Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 47. Australia Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 48. Rest of Asia-Pacific Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 49. Rest of Asia-Pacific Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 50. Rest of Asia-Pacific Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 51. Europe Neuroprosthetics, by Country USD Million (2016-2021)
  • Table 52. Europe Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 53. Europe Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 54. Europe Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 55. Germany Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 56. Germany Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 57. Germany Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 58. France Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 59. France Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 60. France Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 61. Italy Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 62. Italy Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 63. Italy Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 64. United Kingdom Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 65. United Kingdom Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 66. United Kingdom Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 67. Netherlands Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 68. Netherlands Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 69. Netherlands Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 70. Rest of Europe Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 71. Rest of Europe Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 72. Rest of Europe Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 73. MEA Neuroprosthetics, by Country USD Million (2016-2021)
  • Table 74. MEA Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 75. MEA Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 76. MEA Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 77. Middle East Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 78. Middle East Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 79. Middle East Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 80. Africa Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 81. Africa Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 82. Africa Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 83. North America Neuroprosthetics, by Country USD Million (2016-2021)
  • Table 84. North America Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 85. North America Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 86. North America Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 87. United States Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 88. United States Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 89. United States Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 90. Canada Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 91. Canada Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 92. Canada Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 93. Mexico Neuroprosthetics, by Type USD Million (2016-2021)
  • Table 94. Mexico Neuroprosthetics, by Application USD Million (2016-2021)
  • Table 95. Mexico Neuroprosthetics, by Technology USD Million (2016-2021)
  • Table 96. Neuroprosthetics: by Type(USD/Units)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Neuroprosthetics: by Type(USD Million)
  • Table 105. Neuroprosthetics Output Neural Prosthetics , by Region USD Million (2022-2027)
  • Table 106. Neuroprosthetics Input Neural Prosthetics , by Region USD Million (2022-2027)
  • Table 107. Neuroprosthetics: by Application(USD Million)
  • Table 108. Neuroprosthetics Motor Neuron Disorders , by Region USD Million (2022-2027)
  • Table 109. Neuroprosthetics Physiological Disorders , by Region USD Million (2022-2027)
  • Table 110. Neuroprosthetics Cognitive Disorders , by Region USD Million (2022-2027)
  • Table 111. Neuroprosthetics: by Technology(USD Million)
  • Table 112. Neuroprosthetics Deep Brain Stimulation (DBS) , by Region USD Million (2022-2027)
  • Table 113. Neuroprosthetics Vagus Nerve Stimulation (VNS) , by Region USD Million (2022-2027)
  • Table 114. Neuroprosthetics Spinal Cord Stimulation (SCS) , by Region USD Million (2022-2027)
  • Table 115. Neuroprosthetics Sacral Nerve Stimulation (SNS) , by Region USD Million (2022-2027)
  • Table 116. South America Neuroprosthetics, by Country USD Million (2022-2027)
  • Table 117. South America Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 118. South America Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 119. South America Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 120. Brazil Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 121. Brazil Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 122. Brazil Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 123. Argentina Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 124. Argentina Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 125. Argentina Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 126. Rest of South America Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 127. Rest of South America Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 128. Rest of South America Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 129. Asia Pacific Neuroprosthetics, by Country USD Million (2022-2027)
  • Table 130. Asia Pacific Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 131. Asia Pacific Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 132. Asia Pacific Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 133. China Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 134. China Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 135. China Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 136. Japan Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 137. Japan Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 138. Japan Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 139. India Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 140. India Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 141. India Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 142. South Korea Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 143. South Korea Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 144. South Korea Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 145. Taiwan Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 146. Taiwan Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 147. Taiwan Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 148. Australia Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 149. Australia Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 150. Australia Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 151. Rest of Asia-Pacific Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 152. Rest of Asia-Pacific Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 153. Rest of Asia-Pacific Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 154. Europe Neuroprosthetics, by Country USD Million (2022-2027)
  • Table 155. Europe Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 156. Europe Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 157. Europe Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 158. Germany Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 159. Germany Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 160. Germany Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 161. France Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 162. France Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 163. France Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 164. Italy Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 165. Italy Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 166. Italy Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 167. United Kingdom Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 168. United Kingdom Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 169. United Kingdom Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 170. Netherlands Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 171. Netherlands Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 172. Netherlands Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 173. Rest of Europe Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 174. Rest of Europe Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 175. Rest of Europe Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 176. MEA Neuroprosthetics, by Country USD Million (2022-2027)
  • Table 177. MEA Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 178. MEA Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 179. MEA Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 180. Middle East Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 181. Middle East Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 182. Middle East Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 183. Africa Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 184. Africa Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 185. Africa Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 186. North America Neuroprosthetics, by Country USD Million (2022-2027)
  • Table 187. North America Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 188. North America Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 189. North America Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 190. United States Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 191. United States Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 192. United States Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 193. Canada Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 194. Canada Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 195. Canada Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 196. Mexico Neuroprosthetics, by Type USD Million (2022-2027)
  • Table 197. Mexico Neuroprosthetics, by Application USD Million (2022-2027)
  • Table 198. Mexico Neuroprosthetics, by Technology USD Million (2022-2027)
  • Table 199. Neuroprosthetics: by Type(USD/Units)
  • Table 200. Research Programs/Design for This Report
  • Table 201. Key Data Information from Secondary Sources
  • Table 202. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Neuroprosthetics: by Type USD Million (2016-2021)
  • Figure 5. Global Neuroprosthetics: by Application USD Million (2016-2021)
  • Figure 6. Global Neuroprosthetics: by Technology USD Million (2016-2021)
  • Figure 7. South America Neuroprosthetics Share (%), by Country
  • Figure 8. Asia Pacific Neuroprosthetics Share (%), by Country
  • Figure 9. Europe Neuroprosthetics Share (%), by Country
  • Figure 10. MEA Neuroprosthetics Share (%), by Country
  • Figure 11. North America Neuroprosthetics Share (%), by Country
  • Figure 12. Global Neuroprosthetics: by Type USD/Units (2016-2021)
  • Figure 13. Global Neuroprosthetics share by Players 2021 (%)
  • Figure 14. Global Neuroprosthetics share by Players (Top 3) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Medtronic (United States) Revenue, Net Income and Gross profit
  • Figure 17. Medtronic (United States) Revenue: by Geography 2021
  • Figure 18. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 19. Abbott (United States) Revenue: by Geography 2021
  • Figure 20. Cochlear (Australia) Revenue, Net Income and Gross profit
  • Figure 21. Cochlear (Australia) Revenue: by Geography 2021
  • Figure 22. Boston Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 23. Boston Scientific (United States) Revenue: by Geography 2021
  • Figure 24. Livanova (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 25. Livanova (United Kingdom) Revenue: by Geography 2021
  • Figure 26. Second Sight (United States) Revenue, Net Income and Gross profit
  • Figure 27. Second Sight (United States) Revenue: by Geography 2021
  • Figure 28. Med-El (Austria) Revenue, Net Income and Gross profit
  • Figure 29. Med-El (Austria) Revenue: by Geography 2021
  • Figure 30. Global Neuroprosthetics: by Type USD Million (2022-2027)
  • Figure 31. Global Neuroprosthetics: by Application USD Million (2022-2027)
  • Figure 32. Global Neuroprosthetics: by Technology USD Million (2022-2027)
  • Figure 33. South America Neuroprosthetics Share (%), by Country
  • Figure 34. Asia Pacific Neuroprosthetics Share (%), by Country
  • Figure 35. Europe Neuroprosthetics Share (%), by Country
  • Figure 36. MEA Neuroprosthetics Share (%), by Country
  • Figure 37. North America Neuroprosthetics Share (%), by Country
  • Figure 38. Global Neuroprosthetics: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Medtronic (United States)
  • Abbott (United States)
  • Cochlear (Australia)
  • Boston Scientific (United States)
  • Livanova (United Kingdom)
  • Second Sight (United States)
  • Med-El (Austria)
Additional players considered in the study are as follows:
Sonova (Switzerland) , Neuropace (United States) , NDI Medical (United States) , Nevro (United States)
Select User Access Type

Key Highlights of Report


Jul 2022 168 Pages 91 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Neuroprosthetics Market Quantitative research analysis
Global Neuroprosthetics Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The prominent players of Global Neuroprosthetics market are Medtronic (United States), Abbott (United States), Cochlear (Australia), Boston Scientific (United States), Livanova (United Kingdom), Second Sight (United States) and Med-El (Austria).
In this highly competitive & fast evolving Neuroprosthetics industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.
Motor Neuron Disorders, Physiological Disorders and Cognitive Disorders are the potential customers of Neuroprosthetics industry.
The Global Neuroprosthetics market is expected to see a growth of 11.9% during projected year 2021 to 2027.

Know More About Global Neuroprosthetics Market Report?

Have a Query? Click Here

Other Related Reports

Dental Biomaterials Comprehensive Study by Type (Metallic Biomaterials, Titanium, Stainless Steel, Chromium Alloys, Other Metallic Biomaterials, Metal-ceramic Biomaterials, Ceramic Biomaterials, Poly...
$ 3750
Orthodontic Brackets  Comprehensive Study by Type (Conventional Brackets, Self-ligating Brackets, Lingual Brackets), Application (Children, Adult), Material (Metallic, Aesthetic {Plastic, Ceramic}, ...
$ 3450
Plaster Cast Comprehensive Study by Type (Gauze Plaster Cast, Elastic Plaster Cast, Polymer Plaster Cast, Others), Material (Polyester, Polyethylene, Fiberglass, Plaster of Paris, Other), Casting Eq...
$ 3650
Hydrogel Dressing Comprehensive Study by Type (Sheet Hydrogel Dressings, Impregnated Hydrogel Dressings, Amorphous Hydrogel Dressings), Application (Surgical Wounds, Ulcers, Burns, Inpatient Faciliti...
$ 3650
Personal Lancets Comprehensive Study by Type (21G, 26G, 28G, 30G, 33G, Others), Application (Glucose Testing, Hemoglobin Testing, Coagulation Testing, Other Applications), Distribution Channel (Onlin...
$ 3450
Ibuprofen Comprehensive Study by Type (USP, EP), Application (Tablet, Capsule, Suspension, Other), End users (Adults, Children) Players and Region - Global Market Outlook to 2030
$ 3500